Wolfe Research Raises Merck Price Target to $180

Wolfe Research has raised its price target for Merck (no ticker mentioned) to $180 from $155, according to TipRanks. The firm's Smart Score performance is based on backtested results, which are not an indicator of future actual results.

The backtested performance reflects the results of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The assumptions used for modeling purposes include that XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading.

Changes in these assumptions may have a material impact on the backtested returns presented. No representations and warranties are made as to the reasonableness of the assumptions, and this information is provided for illustrative purposes only.